You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anagliptin

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Efficacy and Safety of Anagliptin Switching From Other DPP4is in

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Anagliptin
  • Bucheon, Korea, Republic of
    The Catholic University of Korea, Bucheon ST. Mary's hopsital
Apr 28, 2021

Dipeptidyl-Peptidase 4 Inhibitors, LDL Cholesterol, Glycosylated Hemoglobin Trial in Tomishiro (Anagliptin, Sitagliptin)

Completed
  • Dipeptidyl-Peptidase 4 Inhibitors
  • +4 more
  • Tomishiro, Okinawa, Japan
    Department of Cardiovascular Medicine, Tomishiro Central Hospita
Aug 22, 2019

Type 2 Diabetes Trial in Seoul (Anagliptin, Sitagliptin)

Completed
  • Type 2 Diabetes Mellitus
  • Seoul, Korea, Republic of
    Kangbuk Samsung Hospital
May 12, 2014

Type 2 Diabetes Trial in Seoul (Anagliptin, Placebo of Anagliptin)

Completed
  • Type 2 Diabetes Mellitus
  • Anagliptin
  • Placebo of Anagliptin
  • Seoul, Korea, Republic of
    Kangbuk Samsung Hospital
Jan 2, 2013